10.1002/chem.201704261
Chemistry - A European Journal
COMMUNICATION
2007, 317, 1881-1886; (d) R. Poulin; L. Lu; B. Ackermann; P. Bey; A. E.
Pegg, J. Biol. Chem. 1992, 267, 150-158.
Attempt to perform tri-substitution by increasing the reaction
temperature to above 100 °C solely resulted in decomposition
(Scheme 3).
Based on our observation and the recent mechanistic
studies,12g,12h,19,20 we propose the mechanism depicted in
Scheme 6 for mono-difluoromethylation of quinoline. Specifically,
we proposed that the formation of difluoromethyl radical is evoked
by silver-catalyzed oxidative decarboxylation of difluoroacetic
acid and subsequent addition to the heteroaromatic ring.
[4]
There are six other drugs containing CF2H: zardaverine, D0870, RS
71684, flucythrinate, foridon and devacoxib. However, It should be noted
that roflumilast, pantoprazole, zardaverine, RS 71684 and flucythrinate
are actually containing -OCF2H not carbon-bonded -CF2H.
N.A. Meanwell, J. Med. Chem. 2011, 54, 2529-2591.
[5]
[6]
a) G.W. Rewcastle, S.A. Gamage, J.U. Flanagan, R. Frederick, W.A.
Denny, B.C. Baguley, P. Kestell, R. Singh, J.D. Kendall, E.S. Marshall,
C.L. Lill, W.J. Lee, S. Kolekar, C.M Buchanan, S.M. Jamieson, P.R.
Shepherd, J. Med. Chem. 2011, 54, 7105-7126. b) Y. Zafrani, D. Yeffet,
G. Sod-Moriah, A. Berliner, D. Amir, D. Marciano, E. Gershonov, S.
Saphier, J. Med. Chem. 2017, 60, 797–804.
[7]
[8]
[9]
T. Furuya, C. Kuttruff, T. Ritter, Curr. Opin. Drug Disc. Dev. 2008, 11,
803−819.
T. Liang, C. N. Neumann, T. Ritter, Angew. Chem. Int. Ed. 2013, 52,
8214–8264.
For recent review see: J. Rong, C. Ni, J. Hu, Asian J. Org. Chem. 2017,
6, 139; and references therein.
[10] a) L. N. Markovski, V. E. Pahinnik, A. V. Kirsanov, Synthesis. 1973,
787−789; b) T. Umemoto, R. P. Singh, Y. Xu, N. Saito, J. Am. Chem.
Soc. 2010, 132, 18199.
Scheme 6. Plausible mechanism for mono-difluoromethylation. Proposed
mechanism for mono-difluoromethylation of quinoline.21
[11] a) Y. Gu, X. Leng, Q. Shen, Nat. Commun. 2014, 5, 5405; b) L. Xu, D.A.
Vicic, J. Am. Chem. Soc. 2016,138, 2536-2539.
[12] For recent methods of difluoromethylation of Aryl Halides see: a) H.
Serizawa, K. Ishii, K. Aikawa, K. Mikami, Org. Lett. 2016, 18, 3686–3689;
b) K. Aikawa, H. Serizawa, K. Ishii, K. Mikami, Org. Lett. 2016, 18, 3690–
3693; c) G. K. Prakash, S. K. Ganesh, J. P. Jones, A. Kulkarni, K.
Masood, J. K. Swabeck, G. A. Olah, Angew. Chem. Int. Ed. 2012, 51,
12090-12094. d) P. S. Fier, J. F. Hartwig, J Am Chem Soc. 2012, 134,
5524-5527. e) R.B. James, K.K. Stavros, S.S. Melanie, Organometallics.
2017, 36, 1220. f) C. Lu, Y. Gu, J. Wu, Y. Gub, Q. Shen, Chem. Sci.,
2017, 8, 4848. Difluoromethylation of Aryl boronic acid: g) Z. Feng, Q.
Min, X. Zhang, Org. Lett. 2016, 18, 44–47; h) Z. Feng, Q. Min, X. Fu, L.
An, X. Zhang, Nat. Chem. 2017, 9, 918. Sandmeyer difluoromethylation
of (hetero-)arenediazonium salts see: i) C. Matheis, K. Jouvin, L. J.
Goossen, Org Lett, 2014, 16, 5984-5987. Preparation of
difluoromethylated compounds via silver-catalyzed decarboxylation of α-
fluoroarylacetatic acids and α,α-difluoroarylacetic acids see: j) S. Mizuta,
I. S. R. Stenhagen, M. ODuill, J. Wolstenhulme, A. K. Kirjavainen, S. J.
Forsback, M. Tredwell, G. Sandford, P. R. Moore, M. Huiban, S. K.
Luthra, J. Passchier, O. Solin, V. Gouverneur, Org. Lett. 2013, 15, 2648;
k) F. Chen, A. S. K. Hashmi, Org. Lett. 2016, 18, 2880-2882. l) There is
one method for silver-catalyzed C-H trifluoromethylation of arenes using
trifluoroacetic acid: G. Shi, C. Shao, S. Pan, J. Yu, Y. Zhang, Org. Lett.
2015, 17, 38.
In conclusion, we have discovered that difluoroacetic acid
can be used as a new reagent for innate C-H difluoromethylation
of heteroaromatic compounds. The procedure presented is
technically simple, scalable, inexpensive, controllable and a direct
C-H activation synthetic methodology for preparation of both
mono- and bis-difluoromethylated derivatives of N-containing
heteroaromatics. Remarkably, the present protocol employs the
easily accessible and off-the-shelf difluoroacetic acid as starting
material. Furthermore, the late-stage one-step access to bis-
difluoromethylated products is novel and has enabled synthesis
of several compounds, which were not available using previously
reported reaction conditions. Since the protocol makes a broad
number of difluoromethylated derivatives of heteroaromatic
compounds available, this report enables preparation of previous
inaccessible tool compounds for biological assays and predictably
important lead structures for drug discovery. Intensive studies on
the mechanism as well as expanding the scope of this reaction
are currently being performed in our lab.
[13] Y. Fujiwara, J.A. Dixon, R.A. Rodriguez, R.D. Baxter, D.D Dixon, M.R.
Collins, D.G. Blackmond, P.S. Baran, J. Am. Chem. Soc. 2012, 134,
1494-1497.
Acknowledgements
[14] Y. Fujiwara, J. A. Dixon, F. O'Hara, E. D. Funder, D. D. Dixon, R. A.
Rodriguez, R. D. Baxter, B. Herlé, N. Sach, M. R. Collins, Y. Ishihara, P.
S. Baran, Nature. 2012, 492, 95-99; and references therein.
This work was supported by the University of Copenhagen
Excellency Program for Interdisciplinary Excellence (UC2016).
[15] T.T. Tung, T.H. Jakobsen, T.T. Dao, A.T. Fuglsang, M. Givskov, S.B.
Christensen, J. Nielsen, Eur. J. Med. Chem. 2016, 126, 1011-1020.
[16] a) F. Minisci, R. Bernardi, F. Bertini, R. Galli, M. Perchinummo,
Tetrahedron. 1971, 27, 3575–3579; b) F. Minisci, E. Vismara, F. Fontana,
Heterocycles. 1989, 28, 489-519.
Keywords: difluoromethylation • difluoroacetic acid • bis-
difluoromethylation • radicals
[1]
[2]
A. Vulpetti, C. Dalvit, Drug. Discov. Today. 2012, 17, 890-897.
[17] A. J. Duncton, Med. Chem. Commun. 2011, 2, 1135−1161.
[18] See page s15 in supporting information for full proposed mechanism.
[19] (a) N. R. Patel, R. A. Flowers II, J. Am. Chem. Soc. 2013, 135, 4672; (b)
N. R. Patel, R. A. Flowers II, J. Org. Chem. 2015, 80, 5834-5841.
[20] R. D. Baxter, Y. Liang, X. Hong, T. A. Brown, R. N. Zare, K. N. Houk, P.
S. Baran, D. G. Blackmond, ACS Cent. Sci. 2015, 1, 456–46.
[21] See page S4 in ESI for full proposed mechanism.
J. Wang, M. Sánchez-Roselló, J.L. Aceña, C.D. Pozo, A.E. Sorochinsky,
S. Fustero, V.A. Soloshonok, H. Liu, Chem. Rev. 2014, 114, 2432-2506.
a) E. P. Gillis, K. J. Eastman, M. D. Hill, D. J. Donnelly, N. A. Meanwell,
J. Med. Chem. 2015, 58, 8315-8359; b) I. Ojima in Fluorine in Medicinal
Chemistry and Chemical Biology, (Eds.: I. Ojima), Wiley-VCH, Weinheim,
2009; c) S. Purser, P. R. Peter, S. Swallow, V. Gouverneur, Chem. Soc.
Rev. 2008, 37, 320-330; d) K. Müller, C. Faeh, F. Diederich, Science.
[3]
This article is protected by copyright. All rights reserved.